The Enterprise Value as of December 2025 (TTM) for General Biologicals Corporation (4117.TWO) is 3.11B

According to General Biologicals Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 3.11B. This represents a change of 6.91% compared to the average of 2.91B of the last 4 quarters.

General Biologicals Corporation (4117.TWO) Historical Enterprise Value (quarterly & annually)

How has 4117.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of General Biologicals Corporation over the last ten years is 2.07B. The current 3.11B Enterprise Value has changed 14.92% with respect to the historical average. Over the past ten years (40 quarters), 4117.TWO's Enterprise Value was at its highest in in the June 2025 quarter at 3.34B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

General Biologicals Corporation (4117.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of General Biologicals Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

General Biologicals Corporation (4117.TWO) Average Enterprise Value

How has 4117.TWO Enterprise Value performed in the past?

The current Enterprise Value of General Biologicals Corporation (4117.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

General Biologicals Corporation (4117.TWO) Enterprise Value vs. Peers

How is 4117.TWO’s Enterprise Value compared to its peers?

General Biologicals Corporation’s Enterprise Value is greater than Radiant Innovation Inc. (750.16M), greater than S&S Healthcare Holding Ltd. (797.98M), greater than Andros Pharmaceuticals Co.,Ltd (1.22B), greater than Healthconn Corp. (972.64M), greater than PlexBio Co., Ltd. (699.37M), greater than Concord Medical Co., Ltd. (943.68M), greater than SynCore Biotechnology Co.,Ltd (729.20M), greater than TFBS Bioscience Inc. (528.49M), greater than Eusol Biotech Co.,Ltd. (682.65M), greater than Amed Co., Ltd. (1.32B),

Build a custom stock screener for General Biologicals Corporation (4117.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like General Biologicals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

General Biologicals Corporation (4117.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like General Biologicals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.